US 2006/0223747 A1Published application

Therapeutic agent for soft tissue sarcoma

AssigneeFujisawa Pharmaceutical Co., Ltd.

InventorsTatsuo Ito, Toshifumi Ozaki, Mamoru Ouchida

Life of this patent

Estimating the term…

Abstract

A therapeutic agent for soft tissue sarcoma (particularly synovial sarcoma) contains a histone deacetylase inhibitor (particularly compound of formula I) as an active ingredient

Claims11

Dependent claims

1-8. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 11/370,363Filed 8 Mar 2006
Priority: JP 2003-18364327 Jun 2003
Published: 5 Oct 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 38/005
Medicinal preparations containing peptides: enzyme inhibitors
A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid
A61K 31/4406
Non condensed pyridines; Hydrogenated derivatives thereof: only substituted in position 3, e.g. zimeldine
A61K 38/12
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof: cyclic peptides , e.g. bacitracins; Polymyxins; Gramicidins…

Family

Application10/875,382Continuation · filed 25 Jun 2004
Application11/370,363Continuation · filed 8 Mar 2006
US 2005/0107290 A1Published application
US 7,056,883 B2Related patent
US 2006/0223747 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…